This site uses cookies to collect activity data and personalize content. By continuing to navigate this site, you agree to allow us to collect information using cookies. Learn more about how we care for your data in our privacy notice.

Accept
Pandemic response
COVID-19 is impacting communities around the world. PATH and our partners are responding.

PATH Resources

Our online catalog indexes publications, presentations, and related resources for peers in our field.

48 Resources
48 Resources
48 Resources
    Date
  1. Breastfeeding and the use of human milk (expressed breastmilk and donor human milk) are important for improved neonatal outcomes at all times and are of particular importance during emergencies and natural calamities. This is a guidance note prepared for health facilities and the Comprehensive Lactation Management Centres (with Human Milk Banks) on the use of human milk during COVID-19.
    Published: May 2020
    Type: Resource Page
  2. This fact sheet describes PATH’s work in collaboration with the government of India and other partners to expand use of fortified rice in India. Studies have shown that fortified rice is a powerful intervention to combat micronutrient malnutrition, especially among women and young children
    Published: March 2020
    Type: Resource Page
  3. Research highlights that Indian children are among the worst sufferers of malnutrition that includes vitamin and mineral deficiencies. PATH collaborated with the Government of Karnataka, and partners to increase the spread of fortified rice under the Mid Day Meal (MDM) in government schools of Karnataka. This study assesses the impact of consumption of fortified rice on nutritional and health indicators among school children in Karnataka.
    Published: March 2020
    Type: Resource Page
  4. This slide provides a snapshot of the respiratory syncytial virus (RSV) vaccine and monoclonal antibody (mAb) technology landscape, in the effort to track the development of RSV vaccine and mAb candidates and provide a summary of the various vaccine approaches being worked on worldwide. (This snapshot pairs with the RSV and mAb Trial Tracker, which provides publicly available information on clinical trials of RSV candidate vaccines and mAbs intended for prevention.)
    Published: March 2020
    Type: Resource Page
  5. In low- and middle-income countries, many women experience anemia during pregnancy due to insufficient dietary intake of key micronutrients, parasitic infections, hemoglobinopathies, and chronic infections. Maternal anemia increases perinatal risks for both mothers and infants, and slow progress to reduce the prevalence may be due in part to the lack of affordable tools to quantify hemoglobin levels in antenatal care (ANC) clinics. A simple, inexpensive, accurate, and robust diagnostic is needed to measure hemoglobin in ANC.PATH sought to understand and assess the accuracy and operational fit of current anemia diagnostic tools. Our approach began with the development of a target product profile and a landscape of commercially available/emerging diagnostics for anemia testing.We then identified promising candidate technologies and conducted laboratory verification testing and usability testing in a representative ANC setting.This project resulted in a body of evidence that can be used to evaluate and select promising anemia diagnostic technologies to take to scale now and in the future.
    Published: March 2020
    Type: Resource Page
Load more